96 related articles for article (PubMed ID: 32298002)
1. Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome.
Moolla A; de Boer J; Pavlov D; Amin A; Taylor A; Gilligan L; Hughes B; Ryan J; Barnes E; Hassan-Smith Z; Grove J; Aithal GP; Verrijken A; Francque S; Van Gaal L; Armstrong MJ; Newsome PN; Cobbold JF; Arlt W; Biehl M; Tomlinson JW
Aliment Pharmacol Ther; 2020 Jun; 51(11):1188-1197. PubMed ID: 32298002
[TBL] [Abstract][Full Text] [Related]
2. Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation study.
Miller H; Harman D; Aithal GP; Manousou P; Cobbold JF; Parker R; Sheridan D; Newsome PN; Karpe F; Neville M; Arlt W; Sitch AJ; Korbonits M; Biehl M; Alazawi W; Tomlinson JW
BMJ Open; 2024 Jan; 14(1):e074918. PubMed ID: 38238179
[TBL] [Abstract][Full Text] [Related]
3. Fungal signature differentiates alcohol-associated liver disease from nonalcoholic fatty liver disease.
Viebahn G; Hartmann P; Lang S; Demir M; Zhang X; Fouts DE; Stärkel P; Schnabl B
Gut Microbes; 2024; 16(1):2307586. PubMed ID: 38298161
[TBL] [Abstract][Full Text] [Related]
4. Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease.
Aravinthan A; Mells G; Allison M; Leathart J; Kotronen A; Yki-Jarvinen H; Daly AK; Day CP; Anstee QM; Alexander G
Cell Cycle; 2014; 13(9):1489-94. PubMed ID: 24626178
[TBL] [Abstract][Full Text] [Related]
5. Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests.
Boursier J; Roux M; Costentin C; Chaigneau J; Fournier-Poizat C; Trylesinski A; Canivet CM; Michalak S; Le Bail B; Paradis V; Bedossa P; Sturm N; de Ledinghen V; ; ; Newsome PN
Nat Commun; 2023 Aug; 14(1):5219. PubMed ID: 37633932
[TBL] [Abstract][Full Text] [Related]
6. A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures.
Govaere O; Hasoon M; Alexander L; Cockell S; Tiniakos D; Ekstedt M; Schattenberg JM; Boursier J; Bugianesi E; Ratziu V; ; Daly AK; Anstee QM
Nat Metab; 2023 Apr; 5(4):572-578. PubMed ID: 37037945
[TBL] [Abstract][Full Text] [Related]
7. Reply: Machine learning models for NAFLD/NASH and cirrhosis diagnosis and staging: accuracy and routine variables are the success keys.
Chang D; Truong E; Noureddin M
Hepatology; 2023 May; 77(5):E105-E106. PubMed ID: 37018138
[No Abstract] [Full Text] [Related]
8. Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease.
Nazari E; Khalili-Tanha G; Asadnia A; Pourali G; Maftooh M; Khazaei M; Nasiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
Sci Rep; 2023 Nov; 13(1):20489. PubMed ID: 37993474
[TBL] [Abstract][Full Text] [Related]
9. Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach.
Chang H; Meng HY; Liu SM; Wang Y; Yang XX; Lu F; Wang HY
Sci Rep; 2017 Sep; 7(1):11433. PubMed ID: 28900168
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive fibrosis assessment in non-alcoholic fatty liver disease.
Rios RS; Zheng KI; Targher G; Byrne CD; Zheng MH
Chin Med J (Engl); 2020 Nov; 133(22):2743-2745. PubMed ID: 32932282
[No Abstract] [Full Text] [Related]
11. A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression.
Perveen S; Shahbaz M; Keshavjee K; Guergachi A
Sci Rep; 2018 Feb; 8(1):2112. PubMed ID: 29391513
[TBL] [Abstract][Full Text] [Related]
12. Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers.
Terracciani F; Falcomatà A; Gallo P; Picardi A; Vespasiani-Gentilucci U
J Physiol Biochem; 2023 Nov; 79(4):851-868. PubMed ID: 36472795
[TBL] [Abstract][Full Text] [Related]
13. Could protein content of Urinary Extracellular Vesicles be useful to detect Cirrhosis in Alcoholic Liver Disease?
Gonzalez E; Azkargorta M; Garcia-Vallicrosa C; Prieto-Elordui J; Elortza F; Blanco-Sampascual S; Falcon-Perez JM
Int J Biol Sci; 2021; 17(8):1864-1877. PubMed ID: 34131392
[TBL] [Abstract][Full Text] [Related]
14. Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD.
Kang W; Kim SU
Clin Mol Hepatol; 2013 Sep; 19(3):255-7. PubMed ID: 24133662
[No Abstract] [Full Text] [Related]
15. Six-gene prognostic signature for non-alcoholic fatty liver disease susceptibility using machine learning.
Zhang X; Zhou C; Hu J; Hu J; Ding Y; Chen S; Wang X; Xu L; Gou Z; Zhang S; Shi W
Medicine (Baltimore); 2024 May; 103(19):e38076. PubMed ID: 38728481
[TBL] [Abstract][Full Text] [Related]
16. Use of invasive cardiopulmonary exercise testing to diagnose preload reserve failure in patients with liver disease.
Ahlers CG; Patel P; Parikh K; Fudim M
ESC Heart Fail; 2024 Feb; 11(1):587-593. PubMed ID: 38012064
[TBL] [Abstract][Full Text] [Related]
17. The Influence of Sex Hormones in Liver Function and Disease.
Kasarinaite A; Sinton M; Saunders PTK; Hay DC
Cells; 2023 Jun; 12(12):. PubMed ID: 37371074
[TBL] [Abstract][Full Text] [Related]
18. The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease.
Qadri S; Wang X; Tran C; Fitzpatrick M; Bonnitcha P; Sullivan D; Yki-Järvinen H; O'Sullivan JF
Pathology; 2024 Apr; 56(3):391-397. PubMed ID: 38071157
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive proteomic biomarkers for alcohol-related liver disease.
Niu L; Thiele M; Geyer PE; Rasmussen DN; Webel HE; Santos A; Gupta R; Meier F; Strauss M; Kjaergaard M; Lindvig K; Jacobsen S; Rasmussen S; Hansen T; Krag A; Mann M
Nat Med; 2022 Jun; 28(6):1277-1287. PubMed ID: 35654907
[TBL] [Abstract][Full Text] [Related]
20. Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.
Schiffer L; Barnard L; Baranowski ES; Gilligan LC; Taylor AE; Arlt W; Shackleton CHL; Storbeck KH
J Steroid Biochem Mol Biol; 2019 Nov; 194():105439. PubMed ID: 31362062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
